imvaria Inc

imvaria empowers clinicians to improve patient outcomes through the development and application of modern computer science techniques to complex and serious diseases. The company's Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning. imvaria's lead work is assigned FDA's Breakthrough Device Designation.